99% Savings - Buy Just @1 Rs X
Hospicasp 50 Injection is a commercial drug that is prescribed in the form of Injection. Fungal Infections, Candidal Infection are some of its major therapeutic uses. Secondary and off-label uses of Hospicasp 50 Injection have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Hospicasp 50 Injection. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Hospicasp 50 Injection can also lead to other problems, which have been listed below. Usually, these side effects of Hospicasp 50 Injection go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Hospicasp 50 Injection's effect during pregnancy is Moderate and Moderate while nursing. It is important to know if Hospicasp 50 Injection has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Hospicasp 50 Injection related warnings section.
Other contraindications of Hospicasp 50 Injection have been discussed in the sections ahead.
Besides this, Hospicasp 50 Injection may also have severe interaction with some medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Hospicasp 50 Injection is considered not safe while driving, and is not addictive.
Hospicasp 50 Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
Is the use of Hospicasp 50 Injection safe for pregnant women?
Hospicasp can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Hospicasp right away. Take your doctor's advice before taking it again.
Is the use of Hospicasp 50 Injection safe during breastfeeding?
Hospicasp can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Hospicasp 50 Injection on the Kidneys?
Hospicasp is completely safe for kidneys.
What is the effect of Hospicasp 50 Injection on the Liver?
Hospicasp has very mild side effects on the liver.
What is the effect of Hospicasp 50 Injection on the Heart?
You can take Hospicasp without any fear of damage to the heart.
If you are suffering from any of the following diseases, you should not take Hospicasp 50 Injection unless your doctor advises you to do so -
Is this Hospicasp 50 Injection habit forming or addictive?
Forming a habit of Hospicasp 50 Injection has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Hospicasp 50 Injection as you may feel sleepy.
Is it safe?
Hospicasp 50 Injection should be used only after doctor's advice.
Is it able to treat mental disorders?
Hospicasp 50 Injection is unable to treat or cure mental disorders.
Interaction between Food and Hospicasp 50 Injection
Taking Hospicasp 50 Injection with food does not cause any problems.
Interaction between Alcohol and Hospicasp 50 Injection
Information about the interaction of Hospicasp 50 Injection and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 289-290
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 790
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cancidas® (caspofungin acetate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Caspofungin Myx™ (caspofungin acetate)